In 900 patients with hypertension, the most common adverse events were: See Table 1.
The most common adverse events (>1%) observed in clinical studies of over 2,100 angina and hypertensive patients receiving diltiazem were: See Table 2.
Less common adverse events included the following: See Table 3.
In post-marketing experience, the following additional undesirable effect(s) have been reported: Frequency: Not Known. (See Table 4.)
View ADR Reporting Link
Sign Out